Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
87,434,843
-
Share change
-
+347,232
-
Total reported value
-
$10,272,806,281
-
Put/Call ratio
-
84%
-
Price per share
-
$117.49
-
Number of holders
-
225
-
Value change
-
+$78,572,564
-
Number of buys
-
105
-
Number of sells
-
112
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q3 2017
As of 30 Sep 2017 ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) had 225 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 87,434,843 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, DODGE & COX, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, GOLDMAN SACHS GROUP INC, and PERCEPTIVE ADVISORS LLC.
This table shows 226 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.